Preliminary investigation on eye lens dose measurement during 106Ru plaque making operation
Creators
- 1. Health Safety & Environment Group, Bhabha Atomic Research Centre, Mumbai-400085 (India)
- 2. Process Development Division, Bhabha Atomic Research Centre, Mumbai-400085 (India)
Description
106Ru is used as an important ophthalmic brachytherapy source. High Level Liquid Waste (HLW) from nuclear fuel reprocessing is a rich source of this isotope. BARC has developed an indigenous technology for the fabrication of eye plaque using 106Ru recovered from HLW. The fabrication process has three important steps, separation of pure 106Ru from HLW, electroplating, sealing the source and polishing of plaque. In the present pilot scale facility these steps involves very close handling of the source, resulting in a likelihood of getting significant dose to the eye lens in addition to whole body dose. International Commission of Radiological Protection (ICRP) has revised the life time eye dose threshold for induction of cataract from 2000 mGy to 500 mGy and occupational annual dose limit of eye lenses from 150 to 20 mSv. Hence, it is important to generate data on eye lens dose during the plaque fabrication. The generated data will be useful for optimizing the dose consumption, suggesting engineering automation and also to assure regulatory compliance
Additional details
Publishing Information
- Publisher
- Bhabha Atomic Research Centre
- Imprint Place
- Mumbai (India)
- Imprint Title
- Proceedings of the sixteenth biennial DAE-BRNS symposium on nuclear and radiochemistry: book of abstracts
- Imprint Pagination
- 469 p.
- Journal Page Range
- p. 207
Conference
- Title
- 16. biennial DAE-BRNS symposium on nuclear and radiochemistry
- Acronym
- NUCAR-2023
- Dates
- 1-5 May 2023
- Place
- Mumbai (India)
INIS
- Country of Publication
- India
- Country of Input or Organization
- India
- INIS RN
- 54108360
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Resource subtype / Literary indicator
- Conference
- Descriptors DEI
- BRACHYTHERAPY; CATARACTS; EYES; PLAQUE FORMATION; RADIOPHARMACEUTICALS; RUTHENIUM 106
- Descriptors DEC
- BETA DECAY RADIOISOTOPES; BETA-MINUS DECAY RADIOISOTOPES; BODY; DISEASES; DRUGS; EVEN-EVEN NUCLEI; FACE; HEAD; INTERMEDIATE MASS NUCLEI; ISOTOPES; LABELLED COMPOUNDS; MATERIALS; MEDICINE; NUCLEAR MEDICINE; NUCLEI; ORGANS; RADIOACTIVE MATERIALS; RADIOISOTOPES; RADIOLOGY; RADIOTHERAPY; RUTHENIUM ISOTOPES; SENSE ORGANS; SENSE ORGANS DISEASES; THERAPY; YEARS LIVING RADIOISOTOPES